ACE Research

ACE Research Ace Research is an Africa-based CRO founded in late 2014 and headquartered in Kisumu, Kenya.

A multi-therapeutic full-service CRO providing late phase clinical trial services and solutions to pharmaceutical, global CROs, biotech companies, government, and academic research institutions. It is leading in the development and execution of clinical trials in Africa with access to trained and experienced clinical research professionals and clinical study sites.

09/06/2025

Choosing the right electronic data capture (EDC) system can make or break a trial's success.
An ideal Electronic Data Capture (EDC) system for clinical trials must be secure, user-friendly, and compliant with global regulatory standards such as FDA 21 CFR Part 11, ICH GCP, and GDPR. It should support real-time data entry and validation, audit trails, role-based access control, and integration with other eClinical systems like ePRO, CTMS, and lab data. The system must ensure data integrity through automated edit checks, version control, and secure backup. Additionally, adherence to CDISC standards (e.g., SDTM, ODM) is essential to facilitate data interoperability and regulatory submission readiness.

Sponsors of international clinical trials make common mistakes while choosing an EDC for their research. Here are three common mistakes.

Mistake #1: Overcomplicating the Selection Process
Many sponsors get caught up in the bells and whistles of EDC systems, forgetting the core needs of their trials. They often choose systems with features that are too complex or unnecessary for their specific trials. This leads to confusion among the team and delays in data collection. The focus should be on finding a system that meets the basic needs efficiently, without overwhelming the users at the study sites.

Mistake #2: Ignoring Local Infrastructure Limitations
Some sponsors overlook the technological limitations in Sub-Saharan Africa, opting for EDC systems that require high-speed internet or advanced hardware. This mismatch can lead to frequent disruptions and data loss, undermining the trial's integrity.

Mistake #3: Underestimating Training Needs
Sponsors sometimes assume that users will quickly adapt to new EDC systems without proper training. This oversight can result in errors and inconsistent data entry. A comprehensive training to ensure all users are comfortable and confident with the system is needed prior to site activation.

The Silver Lining
A recent feedback session with trial coordinators revealed a strong desire for simplicity and reliability in EDC systems. This insight has guided us to refine our approach, focusing on user-friendly interfaces and robust support systems. The key takeaway is clear: understanding the local context and user needs is crucial for success.

Recommended strategies:
• Enhance training modules for better user engagement
• Introduce offline & online data entry features
• Simplifying the user interface for ease of use
• Offering personalized support to address specific trial needs

09/06/2025

Choosing the right electronic data capture (EDC) system can make or break a trial's success.

An ideal Electronic Data Capture (EDC) system for clinical trials must be secure, user-friendly, and compliant with global regulatory standards such as FDA 21 CFR Part 11, ICH GCP, and GDPR. It should support real-time data entry and validation, audit trails, role-based access control, and integration with other eClinical systems like ePRO, CTMS, and lab data. The system must ensure data integrity through automated edit checks, version control, and secure backup. Additionally, adherence to CDISC standards (e.g., SDTM, ODM) is essential to facilitate data interoperability and regulatory submission readiness.

Sponsors of international clinical trials make common mistakes while choosing an EDC for their research. Here are three common mistakes.

Mistake #1: Overcomplicating the Selection Process
Many sponsors get caught up in the bells and whistles of EDC systems, forgetting the core needs of their trials. They often choose systems with features that are too complex or unnecessary for their specific trials. This leads to confusion among the team and delays in data collection. The focus should be on finding a system that meets the basic needs efficiently, without overwhelming the users at the study sites.

Mistake #2: Ignoring Local Infrastructure Limitations
Some sponsors overlook the technological limitations in Sub-Saharan Africa, opting for EDC systems that require high-speed internet or advanced hardware. This mismatch can lead to frequent disruptions and data loss, undermining the trial's integrity.

Mistake #3: Underestimating Training Needs
Sponsors sometimes assume that users will quickly adapt to new EDC systems without proper training. This oversight can result in errors and inconsistent data entry. A comprehensive training to ensure all users are comfortable and confident with the system is needed prior to site activation.

The Silver Lining
A recent feedback session with trial coordinators revealed a strong desire for simplicity and reliability in EDC systems. This insight has guided us to refine our approach, focusing on user-friendly interfaces and robust support systems. The key takeaway is clear: understanding the local context and user needs is crucial for success.

Recommended strategies:
• Enhance training modules for better user engagement
• Introduce offline & online data entry features
• Simplifying the user interface for ease of use
• Offering personalized support to address specific trial needs

09/06/2025

Project Command OS template is live!
Get:
- Automated task management with AI
- Ready-to-use project planning workflows
- Integrated SOP management system
Start here. [Link]

🚨 WHO: First Mpox Vaccine Prequalified🚨The World Health Organization (WHO) has added Bavarian Nordic’s Imvanex to its li...
17/09/2024

🚨 WHO: First Mpox Vaccine Prequalified🚨
The World Health Organization (WHO) has added Bavarian Nordic’s Imvanex to its list of prequalified vaccines, a significant step in the fight against mpox. 🌍

WHY IT MATTERS
This designation will allow for faster and broader access to the vaccine, which is crucial during the current global mpox outbreak. 🦠🌐

BACKSTORY
Since 2022, the mpox outbreak has affected over 103,000 individuals across more than 120 countries. 🌎 Imvanex, originally developed as a smallpox vaccine, is now authorized for adults in a two-dose regimen but can be administered as a single dose in outbreak scenarios with limited supply. Although not licensed for those under 18, it can be used in younger populations if the benefits outweigh the risks during outbreaks.

BIG PICTURE
This development is crucial for Africa and for global preparedness for potential future outbreaks. 🌍💪 It emphasizes the urgent need to scale up vaccine procurement, donations, and distribution alongside other public health measures to prevent infections and transmission. The WHO’s prequalification of Imvanex is a significant step in the fight against mpox, enhancing global health security and equity. 🔑

BY NUMBERS
• Over 103,000 mpox cases globally since 2022
• IMVANEX effectiveness: 76% (single dose), 82% (two doses)
• Affected regions: More than 120 countries 📊

READ MORE
🔗 https://www.who.int/news/item/13-09-2024-who-prequalifies-the-first-vaccine-against-mpox

What are your thoughts on this advancement? 💭 Share in the comment section below 👇

🎉ACE Research is proud to be a Silver Sponsor at the Clinical Research Society of Kenya (CRSK) Gala!We are thrilled to s...
19/08/2024

🎉ACE Research is proud to be a Silver Sponsor at the Clinical Research Society of Kenya (CRSK) Gala!

We are thrilled to support this prestigious event, celebrating medical research innovation, collaboration, and the relentless pursuit of excellence in clinical research.

This partnership underscores our dedication to the Kenyan research community and our shared vision for a healthier future. We thank industry leaders, researchers, and collaborators who are as passionate about making a difference as we are.

Happy International Women's Day! Today, we celebrate the strength, resilience, and achievements of women everywhere.💪🌸  ...
08/03/2024

Happy International Women's Day! Today, we celebrate the strength, resilience, and achievements of women everywhere.💪🌸

Join ACE Research at the World Vaccine Congress Washington 2024 on April 1-4 in D.C. Don't miss the chance to network wi...
20/02/2024

Join ACE Research at the World Vaccine Congress Washington 2024 on April 1-4 in D.C. Don't miss the chance to network with industry leaders and discover cutting-edge solutions.

Register today!
https://i.snoball.it/p/6SP5/l/1

The Start-to-Finish of Vaccines From research, immune profiling & clinical trials to manufacture and access!

🎉 Exciting News! ACE Research will be exhibiting at the  World Vaccine Congress 2024! 🌍🗓️ April 1-4, 2024 | 📍 Walter E. ...
15/02/2024

🎉 Exciting News! ACE Research will be exhibiting at the World Vaccine Congress 2024! 🌍

🗓️ April 1-4, 2024 | 📍 Walter E. Washington Convention Center, D.C. | 🏷️ Booth 362

Interested in vaccine clinical trials in Sub-Saharan Africa? Let's chat! Schedule a meeting 👉 https://aceresearchafrica.com/contact-us/

20/12/2023

🎉🎄🎁 All of us here at ACE Research wish you a happy festive holiday season and a prosperous New Year!

Address

The White Court Apartments, Old Airport Road
Kisumu
40100

Opening Hours

Monday 08:00 - 17:00
Tuesday 08:00 - 17:00
Wednesday 08:00 - 17:00
Thursday 08:00 - 17:00
Friday 08:00 - 17:00

Alerts

Be the first to know and let us send you an email when ACE Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share